Have a personal or library account? Click to login
Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation Cover

Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

Global Heart
Volume 17 (2022): Issue 1
By: Louise Bowman,  Franz Weidinger,  Michelle A. Albert,  Edward T. A. Fry,  Fausto J. Pinto and  For the Clinical Trial Expert Group and ESC Patient Forum  
Open Access
|Dec 2022

References

  1. 1Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity. I: clinical trials. Lancet. 2001; 357: 373–380. DOI: 10.1016/S0140-6736(00)03651-5
    Back to article
  2. 2Califf RM. Clinical trials bureaucracy: unintended consequences of well-intentioned policy. Clin Trials. 2006; 3: 496–502. DOI: 10.1177/1740774506073173
    Back to article
  3. 3Eisenstein EL, Collins R, Cracknell BS, Podesta O, Reid ED, Sandercock P, et al. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008; 5: 75–84. DOI: 10.1177/1740774507087551
    Back to article
  4. 4Bowman L, Baras A, Bombien R, Califf RM, Chen Z, Gale CP, et al. Understanding the use of observational and randomized data in cardiovascular medicine. Eur Heart J. 2020; 41: 2571–2578. DOI: 10.1093/eurheartj/ehaa020
    Back to article
  5. 5ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988; 2: 349–360. DOI: 10.1016/S0140-6736(88)92833-4
    Back to article
  6. 6Gruppo Italiano per lo studio della streptochinasi nell’Infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986; 1: 397–402.
    Back to article
  7. 7GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329: 673–682. DOI: 10.1056/NEJM199309023291001
    Back to article
  8. 8Neal B, MacMahon S, Chapman N. Blood pressure lowering treatment trialists C. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists’ collaboration. Lancet. 2000; 356: 1955–1964. DOI: 10.1016/S0140-6736(00)03307-9
    Back to article
  9. 9Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366: 1267–1278. DOI: 10.1016/S0140-6736(05)67394-1
    Back to article
  10. 10Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990– 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020; 396: 1204–1222. DOI: 10.1016/S0140-6736(20)30925-9
    Back to article
  11. 11Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017; 376: 1713–1722. DOI: 10.1056/NEJMoa1615664
    Back to article
  12. 12Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018; 379: 2097–2107. DOI: 10.1056/NEJMoa1801174
    Back to article
  13. 13International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Efficacy Guidelines [Cited Dec 8 2021]. Available from: https://ich.org/page/efficacy-guidelines.
    Back to article
  14. 14Grimes DA, Hubacher D, Nanda K, Schulz KF, Moher D, Altman DG. The good clinical practice guideline: a bronze standard for clinical research. Lancet. 2005; 366: 172–174. DOI: 10.1016/S0140-6736(05)66875-4
    Back to article
  15. 15The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2020; 384: 693–704. DOI: 10.1056/NEJMoa2021436
    Back to article
  16. 16World Health Organization. An international randomised trial of additional treatments for Covid-19 in hospitalised patients who are all receiving the local standard of care 2020 [Cited Dec 8 2021]. Available from: https://www.who.int/publications/m/item/an-international-randomised-trial-of-additional-treatments-for-covid-19-in-hospitalisedpatients-who-are-all-receiving-the-local-standard-of-care.
    Back to article
  17. 17O’Grady C. Poor trials of health steps are worse than none, scientists say. Science. 2021; 374: 1180–1181. DOI: 10.1126/science.acx9739
    Back to article
  18. 18Bugin K, Woodcock J. Trends in COVID-19 therapeutic clinical trials. Nat Rev Drug Discov. 2021; 20: 254–255. DOI: 10.1038/d41573-021-00037-3
    Back to article
  19. 19WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19—interim WHO solidarity trial results. N Engl J Med. 2021; 384: 497–511. DOI: 10.1056/NEJMoa2023184
    Back to article
  20. 20Konstam MA. Real world data as trial End points. Circulation. 2020; 142: 214–216. DOI: 10.1161/CIRCULATIONAHA.120.048019
    Back to article
  21. 21Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013; 369: 1587–1597. DOI: 10.1056/NEJMoa1308789
    Back to article
  22. 22Wallentin L, Gale CP, Maggioni A, Bardinet I, Casadei B. Euroheart: European unified registries on heart care evaluation and randomized trials. Eur Heart J. 2019; 40: 2745–2749. DOI: 10.1093/eurheartj/ehz599
    Back to article
DOI: https://doi.org/10.5334/gh.1178 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Sep 20, 2022
Accepted on: Nov 3, 2022
Published on: Dec 16, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Louise Bowman, Franz Weidinger, Michelle A. Albert, Edward T. A. Fry, Fausto J. Pinto, For the Clinical Trial Expert Group and ESC Patient Forum, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article